Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Arcturus Therapeutics Holdings Inc. develops mRNA-based medicines, focusing on infectious disease vaccines and rare genetic disorders. Its proprietary self-amplifying mRNA (STARR) and lipid nanoparticle delivery (LUNAR) platforms enable low-dose, durable immune responses and targeted therapeutic protein expression. The company’s portfolio includes COVID-19 and influenza vaccines and treatments for ornithine transcarbamylase deficiency and cystic fibrosis, serving global healthcare markets through partnerships and scalable manufacturing.
This description was generated via AI from an annual report. Updated about 1 year ago.